March 28, 2025 - 00:11

OLD GREENWICH, Conn., March 27, 2025 – Ellington Financial Inc. has disclosed its estimated book value per share of common stock, reporting a value of $13.39 as of February 28, 2025. This figure reflects the company's financial performance and includes the impact of a previously declared monthly dividend.
On March 25, 2025, a dividend of $0.13 per share was paid to shareholders who were on record as of February 28, 2025. The ex-dividend date coincided with this record date, allowing investors to benefit from the dividend payment.
The announcement of the estimated book value is an important indicator for investors, as it provides insight into the company's financial health and asset valuation. As the financial landscape continues to evolve, such updates are crucial for stakeholders to assess their investment strategies and expectations regarding future performance. The company remains committed to transparency and will continue to provide updates on its financial metrics.
September 28, 2026 - 02:08
Finance Expert Explains How Kylian Mbappe Can Reach LeBron James Status in the USSoccer finance expert Professor Rob Wilson has shared his perspective on how Kylian Mbappe can build a commercial presence in the United States that rivals stars like LeBron James and Travis Kelce....
September 27, 2026 - 02:05
3 Stocks Tied To Foreign Buying In US Markets Investors May Be MissingForeign buyers have quietly become major forces in US equities. Roughly 942 billion dollars flowed into American shares and funds in the 12 months ending in July, and the second quarter of 2026...
September 26, 2026 - 02:31
MVB Bank Announces Strategic Partnership With DingoBlu FinancialFAIRMONT, W.Va., September 25, 2026 -- DingoBlu Financial, Inc., a financial technology company developing a mobile-first platform for personal financial products, today announced a strategic...
September 25, 2026 - 00:58
NANOBIOTIX Provides First Half 2026 Operational and Financial UpdateNanobiotix has released its operational and financial update for the first half of 2026, highlighting progress across its clinical programs and a significantly improved financial standing. The...